Adaptive Biotechnologies
NASDAQ: ADPTSeattle, US · Founded 2009 · Washington corporation · 5 known investors
Adaptive Biotechnologies applies the genetics of the adaptive immune system to diagnostics and therapeutics, translating immune-system data into clinical insights for clinicians and biopharma companies. Its Immune Medicine Platform is used to detect, monitor, and treat disease.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Founders & leadership
Adaptive Biotechnologies was founded in 2009 by Chad Robins and Harlan Robins.
CR
Chad RobinsCo-founder
HR
Harlan Robinsinco-founder and chief Scientific Officer2010–2026
KD
Kathleen DetermannExecutive
DS
Dean SchornoExecutive
CC
Chris CarlsonNamed on SEC filing
Board
AL
Arnold LevineBoard director
AZ
Andris ZoltnersBoard director
TW
Tom WillisBoard director
PN
Peter NeupertBoard director
JS
John StuelpnagelBoard director
LH
Lee HuntsmanBoard director
RH
Rob HershbergBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$491.6M disclosed across 4 rounds · 2014–2015
▶$195.1MraisedMay 2015 · 16 investors · BiotechnologyRule 506(b)
▶$195.1MraisedMay 2015 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter NeupertDirector
- Andris ZoltnersDirector
- Tom WillisDirector
- Kathleen DetermannExecutive Officer
- Chad RobinsExecutive Officer, Director
- Rob HershbergDirector
- Dean SchornoExecutive Officer
- John StuelpnagelDirector
- Rob RosenDirector
- Chad CohenDirector
- Arnold LevineDirector
- Offering amount
- $195.1M
- Amount sold
- $195.1M
- First sale
- May 2015
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$93.8MraisedJan 2015 · 4 investors · BiotechnologyRule 506(b)
▶$93.8MraisedJan 2015 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rob RosenDirector
- John StuelpnagelDirector
- Chad RobinsExecutive Officer, Director
- Kathleen DetermannExecutive Officer
- Peter NeupertDirector
- Lee HuntsmanDirector
- Dean SchornoExecutive Officer
- Arnold LevineDirector
- Rob HershbergDirector
- Tom WillisDirector
- Andris ZoltnersDirector
- Offering amount
- $93.8M
- Amount sold
- $93.8M
- First sale
- Jan 2015
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$95.7MraisedJan 2015 · 61 investors · BiotechnologyRule 506(b)
▶$95.7MraisedJan 2015 · 61 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Arnold LevineDirector
- Chad RobinsExecutive Officer, Director
- Andris ZoltnersDirector
- Tom WillisDirector
- Kathleen DetermannExecutive Officer
- Peter NeupertDirector
- John StuelpnagelDirector
- Lee HuntsmanDirector
- Rob HershbergDirector
- Rob RosenDirector
- Dean SchornoExecutive Officer
- Offering amount
- $95.7M
- Amount sold
- $95.7M
- First sale
- Jan 2015
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$107MraisedAug 2014 · 6 investors · BiotechnologyRule 506(b)
▶$107MraisedAug 2014 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Harlan RobinsExecutive Officer
- Rob HershbergDirector
- Lee HuntsmanDirector
- Rob RosenDirector
- Chris CarlsonExecutive Officer
- Peter NeupertDirector
- Chad RobinsExecutive Officer, Director
- Arnold LevineDirector
- Andris ZoltnersDirector
- Offering amount
- $107M
- Amount sold
- $107M
- First sale
- Apr 2014
- Incorporated
- Corporation, Washington, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Adaptive Biotechnologies went on to found or lead other companies.
In the news
Frequently asked questions
- What does Adaptive Biotechnologies do?
- Adaptive Biotechnologies applies the genetics of the adaptive immune system to diagnostics and therapeutics, translating immune-system data into clinical insights for clinicians and biopharma companies. Its Immune Medicine Platform is used to detect, monitor, and treat disease.
- Who founded Adaptive Biotechnologies?
- Adaptive Biotechnologies was founded by Chad Robins, Harlan Robins in 2009.
- Who are Adaptive Biotechnologies's investors?
- Adaptive Biotechnologies's investors include Decheng Capital, FMG Capital, Foresite Capital, Khosla Ventures, OrbiMed.
- How much funding has Adaptive Biotechnologies raised?
- Adaptive Biotechnologies has disclosed $491.6M raised across 4 rounds.
- Where is Adaptive Biotechnologies headquartered?
- Adaptive Biotechnologies is headquartered in Seattle, US.